0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Post-transplant cyclophosphamide (PT-Cy) and calcineurin inhibitors used in peripheral blood haplo-identical stem cell transplantation (haploSCT) increase the risk of acute/chronic graft-versus-host disease (GVHD). Whether ATG/PT-Cy is feasible for Asian patients undergoing haploSCT is unclear, and an optimal strategy for GVHD prophylaxis is needed.

          Related collections

          Author and article information

          Journal
          Int J Hematol
          International journal of hematology
          Springer Science and Business Media LLC
          1865-3774
          0925-5710
          Apr 2022
          : 115
          : 4
          Affiliations
          [1 ] Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
          [2 ] College of Medicine, China Medical University, Taichung, 404, Taiwan.
          [3 ] Stem Cell Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
          [4 ] Cancer Center, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
          [5 ] Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan. supengyeh@gmail.com.
          Article
          10.1007/s12185-021-03280-x
          10.1007/s12185-021-03280-x
          35226308
          0b6bca4f-6379-4146-b8f0-a94ac14f33cb
          History

          Haploidentical PBSCT,Sirolimus,ATG
          Haploidentical PBSCT, Sirolimus, ATG

          Comments

          Comment on this article